Industrial Architecture
Bio-Manufacturing
Developing robust frameworks to transition discoveries from the lab bench to high-volume manufacturing with unwavering stability.
Innovation R&D
One strong point of our bio-manufacturing verticals is its innovation R&D. We provide the technical roadmap for transitioning lab-scale discoveries to manufacturing, anticipating and solving for non-linear scale-up dynamics before they impact your CAPEX.
Framework Stability
Engineering robust systems that maintain molecular integrity during mass production. Our bio-reactor architectures ensure identical yields at 10L and 100,000L.
Supply Chain Integration
Ensuring cost-effective deployment of bio-technologies. We optimize every operational constraint so your novel biology integrates seamlessly into legacy logistics.
Technical Specifications
Benchmarking our scale-up protocols against industry baselines.
| Metric | Biodustry Standard | Industry Average |
|---|---|---|
| Yield Parity (Lab to 10kL) | > 96% Retention | 60-80% Retention |
| Contamination Failure Rate | < 0.5% | 2.5% - 5.0% |
| Downstream Processing Efficiency | 88% Recovery | ~65% Recovery |
| Tech Transfer Timeline | 4-6 Months | 12-18 Months |
Predictive Mass-Transfer Modeling for Recombinant Lipase
Overcoming mass-transfer limitations and critical shear stress in high-volume aerobic fermentation. By employing computational fluid dynamics (CFD) and predictive metabolic flux modeling, we architected a bespoke 100,000L bioreactor geometry and agitation protocol. This predictive approach accelerated tech transfer from lab-scale (10L) to commercial manufacturing by 60%, achieving >98% yield parity and unlocking a projected $12M annualized OPEX savings for our partner through superior downstream processing efficiency based on higher titer density.
Transitioning from Lab to Foundry?
De-risk your scale-up with our industrial architecture consulting.
Submit Technical Specs